首站-论文投稿智能助手
典型文献
Co-delivery of doxorubicin and curcumin via cRGD-peptide modified PEG-PLA self-assembly nanomicelles for lung cancer therapy
文献摘要:
Lung cancer is the most common malignancy in the world,with a high mortality rate.Nevertheless,therapies to act effectively against lung cancer remain elusive.So far,chemotherapy is still the frontline treatment of lung cancer.Doxorubicin(DOX)is a broad-spectrum anti-tumor drug.However,DOX of-ten has serious side effects and causes multi-drug resistance,which greatly limits its clinical application.In this work,biodegradable methoxy poly(ethylene glycol)-poly(lactic acid)(MPEG-PLA)and cyclo(Arg-Gly-Asp-D-Phe-Lys)(cRGD)polypeptide modified PEG-PLA(cRGD-PEG-PLA)copolymers were used for the co-delivery of curcumin(CUR)and DOX(CUR-DOX/cRGD-M).The particle size of the self-assembled drug-loaded nanomicelle approximately was 27.4 nm and the zeta potential was-2.7 mV.Interestingly,CUR can enhance the uptake of DOX by Lewis lung carcinoma(LL/2)cells.The experimental results in vivo and in vitro showed that CUR-DOX/cRGD-M combination therapy could promote apoptosis of lung can-cer cells,and conspicuously inhibit the tumor growth.Our data indicate that CUR-DOX/cRGD-M will be biodegradable and sustainable,which may have potential clinical application value in the treatment of lung cancer.
文献关键词:
作者姓名:
Yunchu Zhang;Tingting Li;Yuzhu Hu;Jing Chen;Yihong He;Xiang Gao;Yan Zhang
作者机构:
Department of Thoracic Oncology,Cancer Center,State Key Laboratory of Biotherapy,West China Hospital,West China Medical School,Sichuan University and Collaborative Innovation Center for Biotherapy,Chengdu 610041,China;Department of Neurosurgery and Institute of Neurosurgery,State Key Laboratory of Biotherapy and Cancer Center,West China Hospital,West China Medical School,Sichuan University and Collaborative Innovation Center for Biotherapy,Chengdu 610041,China
引用格式:
[1]Yunchu Zhang;Tingting Li;Yuzhu Hu;Jing Chen;Yihong He;Xiang Gao;Yan Zhang-.Co-delivery of doxorubicin and curcumin via cRGD-peptide modified PEG-PLA self-assembly nanomicelles for lung cancer therapy)[J].中国化学快报(英文版),2022(05):2507-2511
A类:
nanomicelle
B类:
Co,delivery,doxorubicin,curcumin,via,cRGD,modified,PLA,self,assembly,nanomicelles,lung,cancer,Lung,most,common,malignancy,world,high,mortality,rate,Nevertheless,therapies,effectively,against,remain,elusive,So,far,chemotherapy,still,frontline,treatment,Doxorubicin,DOX,broad,spectrum,anti,tumor,drug,However,has,serious,side,effects,causes,multi,resistance,which,greatly,limits,clinical,application,this,work,biodegradable,methoxy,ethylene,glycol,lactic,acid,MPEG,cyclo,Arg,Gly,Asp,Phe,Lys,polypeptide,copolymers,were,used,CUR,particle,size,assembled,loaded,approximately,was,zeta,potential,mV,Interestingly,enhance,uptake,by,Lewis,carcinoma,LL,cells,experimental,results,vivo,vitro,showed,that,combination,could,promote,apoptosis,conspicuously,inhibit,growth,Our,data,indicate,will,be,sustainable,may,have,value
AB值:
0.58555
相似文献
Preparation and functional study of pH-sensitive amorphous calcium phosphate nanocarriers
Baolong Niu;Min Li;Jianhong Jia;Lixuan Ren;Xin Gang;Bin Nie;Yanying Fan;Xiaojie Lian;Wenfeng Li-College of Materials Science and Engineering,Taiyuan University of Technology,Taiyuan 030024,China;Key Laboratory of Interface Science and Engineering in Advanced Materials,Taiyuan University of Technology,Taiyuan 030024,China;School of Basic Medical Sciences,Shanxi Medical University,Taiyuan 030001,China;Department of Biomedical Engineering,Research Center for Nano-biomaterials&Regenerative Medicine,College of Biomedical Engineering,Taiyuan University of Technology,Taiyuan 030024,China;Shanxi Key Laboratory of Material Strength&Structural Impact,Institute of Biomedical Engineering,Taiyuan University of Technology,Taiyuan 030024,China
Multi-responsive nanotheranostics with enhanced tumor penetration and oxygen self-producing capacities for multimodal synergistic cancer therapy
Shuangquan Gou;Nanxi Chen;Xiaoai Wu;Menghang Zu;Shixiong Yi;Binwu Ying;Fangyin Dai;Bowen Ke;Bo Xiao-Laboratory of Anesthesiology & Critical Care Medicine,Department of Anesthesiology,West China Hospital,Sichuan University,Chengdu 610041,China;State Key Laboratory of Silkworm Genome Biology,College of Sericulture,Textile and Biomass Sciences,Southwest University,Chongqing 400715,China;Chongqing Key Laboratory of Soft-Matter Material Chemistry and Function Manufacturing,School of Materials and Energy,Southwest University,Chongqing 400715,China;Department of Nuclear Medicine,West China Hospital,Sichuan University,Chengdu 610041,China;Department of Laboratory Medicine,West China Hospital,Sichuan University,Chengdu 610041,China
Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy
Xianbin Ma;Shaochen Yang;Tian Zhang;Shuo Wang;Qichao Yang;Yao Xiao;Xiaoxiao Shi;Peng Xue;Yuejun Kang;Gang Liu;Zhi-Jun Sun;Zhigang Xu-Key Laboratory of Luminescence Analysis and Molecular Sensing(Southwest University),Ministry of Education,School of Materials and Energy & Chongqing Engineering Research Center for Micro-Nano Biomedical Materials and Devices,Southwest University,Chongqing 400715,China;The State Key Laboratory Breeding Base of Basic Science of Stomatology(Hubei-MOST) & Key Laboratory of Oral Biomedicine,Ministry of Education,School and Hospital of Stomatology,Wuhan University,Wuhan 430079,China;State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine,School of Public Health,Xiamen University,Xiamen 361102,China
A novel PI3K inhibitor XH30 suppresses orthotopic glioblastoma and brain metastasis in mice models
Ming Ji;Dongjie Wang;Songwen Lin;Chunyang Wang;Ling Li;Zhihui Zhang;Jing Jin;Deyu Wu;Yi Dong;Heng Xu;Duo Lu;Xiaoguang Chen-State Key Laboratory of Bioactive Substances and Functions of Natural Medicines,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China
Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation
Qiubing Chen;Qian Li;Yuqi Liang;Menghang Zu;Nanxi Chen;Brandon S.B.Canup;Liyong Luo;Chenhui Wang;Liang Zeng;Bo Xiao-State Key Laboratory of Silkworm Genome Biology,College of Sericulture,Textile,and Biomass Sciences,Southwest University,Chongqing 400715,China;Chongqing Key Laboratory of Soft-Matter Material Chemistry and Function Manufacturing,School of Materials and Energy,Southwest University,Chongqing 400715,China;Department of Chemistry,Center for Diagnostics and Therapeutics,Georgia State University,Atlanta,GA 30303,USA;College of Food Science,Southwest University,Chongqing 400715,China;Chongqing Key Laboratory of Natural Product Synthesis and Drug Research,School of Pharmaceutical Sciences,Chongqing University,Chongqing 401331,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。